Reliability and safety of long-term dabigatran use in patients with atrial fibrillation

The paper presents the data on effectiveness and safety of long-term dabigatranuse for the prevention of thromboembolic complications in patients with atrialfibrillation (AF). The criteria for selecting an optimal dose of dabigatran arediscussed. The authors summarise the results of the current inte...

Full description

Bibliographic Details
Main Authors: E. V. Serdechnaya, S. V. Yurieva, B. A. Tatarskyi
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2013-04-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/364
id doaj-80e9bc850bf542e9815fa25cc23dba48
record_format Article
spelling doaj-80e9bc850bf542e9815fa25cc23dba482021-07-28T14:02:18Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202013-04-0102566010.15829/1560-4071-2013-2-56-60364Reliability and safety of long-term dabigatran use in patients with atrial fibrillationE. V. Serdechnaya0S. V. Yurieva1B. A. Tatarskyi2Northern State Medical University, ArkhangelskNorthern State Medical University, ArkhangelskV.A. Almazov Federal Centre of Heart, Blood, and Endocrinology, St. Petersburg, RussiaThe paper presents the data on effectiveness and safety of long-term dabigatranuse for the prevention of thromboembolic complications in patients with atrialfibrillation (AF). The criteria for selecting an optimal dose of dabigatran arediscussed. The authors summarise the results of the current international andRussian clinical guidelines on dabigatran use in AF patients.https://russjcardiol.elpub.ru/jour/article/view/364atrial fibrillationthromboembolic complicationsstrokehaemorrhageoral anticoagulantsdabigatran
collection DOAJ
language Russian
format Article
sources DOAJ
author E. V. Serdechnaya
S. V. Yurieva
B. A. Tatarskyi
spellingShingle E. V. Serdechnaya
S. V. Yurieva
B. A. Tatarskyi
Reliability and safety of long-term dabigatran use in patients with atrial fibrillation
Российский кардиологический журнал
atrial fibrillation
thromboembolic complications
stroke
haemorrhage
oral anticoagulants
dabigatran
author_facet E. V. Serdechnaya
S. V. Yurieva
B. A. Tatarskyi
author_sort E. V. Serdechnaya
title Reliability and safety of long-term dabigatran use in patients with atrial fibrillation
title_short Reliability and safety of long-term dabigatran use in patients with atrial fibrillation
title_full Reliability and safety of long-term dabigatran use in patients with atrial fibrillation
title_fullStr Reliability and safety of long-term dabigatran use in patients with atrial fibrillation
title_full_unstemmed Reliability and safety of long-term dabigatran use in patients with atrial fibrillation
title_sort reliability and safety of long-term dabigatran use in patients with atrial fibrillation
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2013-04-01
description The paper presents the data on effectiveness and safety of long-term dabigatranuse for the prevention of thromboembolic complications in patients with atrialfibrillation (AF). The criteria for selecting an optimal dose of dabigatran arediscussed. The authors summarise the results of the current international andRussian clinical guidelines on dabigatran use in AF patients.
topic atrial fibrillation
thromboembolic complications
stroke
haemorrhage
oral anticoagulants
dabigatran
url https://russjcardiol.elpub.ru/jour/article/view/364
work_keys_str_mv AT evserdechnaya reliabilityandsafetyoflongtermdabigatranuseinpatientswithatrialfibrillation
AT svyurieva reliabilityandsafetyoflongtermdabigatranuseinpatientswithatrialfibrillation
AT batatarskyi reliabilityandsafetyoflongtermdabigatranuseinpatientswithatrialfibrillation
_version_ 1721269445000691712